Document is current
Any future updates will be listed below
-
Authors
Suzuki, C.
Kiyota, N.
Imamura, Y.
Rikitake, J.
Sai, S.
Koyama, T.
Hyogo, Y.
Nagatani, Y.
Funakoshi, Y.
Toyoda, M.
Otsuki, N.
Nibu, KI.
Minami, H.
- License Information
-
More Information
Article History
Received: 20 November 2019
Accepted: 30 March 2020
First Online: 10 April 2020
Compliance with ethical standards
:
: Dr. Kiyota has received grant support from Eisai, Inc.; research funding from Ono Pharmaceutical and Pfizer; and honoraria from Ono Pharmaceutical, Bristol-Meyers Squibb, Astra Zeneca, Eisai, Bayer and Merck Serono. Dr. Minami has received research funding from Astellas, Bristol-Myers Squibb, Chugai, Dainippon Sumitomo Pharma, Eisai, Kyowa Hakko Kirin, Lilly Japan, Novartis, Ono Pharmaceutical, Sanofi, Taiho, Nippon Shinyaku, MSD, Boehringer Ingelheim, Daiichi Sankyo, Merck Serono, Takeda, Teijin Pharma, Yakult, Asahi Kasei and CSL Behring; and honoraria from Bayer, Bristol-Myers Squibb, Celgene, Chugai, Daiichi-Sankyo, Dainippon Sumitomo, Eisai, Janssen, Kowa, Kyowa Hakko Kirin, Lilly Japan, Merck Serono, Novartis, Ono Pharmaceutical, Otsuka, Pfizer, Sanofi, Shire, Taiho, Takeda and MSD; and has played a consulting/advisory role with Ono Pharmaceutical and Merck Serono. All of the other authors have declared no conflicts of interest.
